General Information
Revision date
2015-11-17
Product name
Diclofenac Sodium Topical Solution USP 1.5% w/w
Icons in SDS
Company Information
company name
SOLA Pharmaceuticals
e-mail address of the competent person responsible for the Safety Data Sheet
info@solameds.us
Section 2
SECTION 2: Hazards identification
Fire and Explosion Health Expected to be non-combustible. Diclofenac sodium is contraindicated in patients with a known hypersensitivity to diclofenac sodium or any other component of diclofenac sodium topical solution. Diclofenac sodium is contraindicated in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Diclofenac sodium is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
